Skip to content

Clinical trials

Recruiting Phase 1/2 Lymphoma, B-Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Phase: Phase 1/2 Status: Recruiting Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20201
20212
20225
20235
20247
20256
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shenzhen University General Hospital3
AstraZeneca2
M.D. Anderson Cancer Center2
AVM Biotechnology Inc1
AbClon1
Affiliated Hospital to Academy of Military Medical Sciences1
Aibin Liang,MD,Ph.D.1
BeOne Medicines1
Beijing Biotech1
CRISPR Therapeutics AG1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell34
Lymphoma, Non-Hodgkin9
Recurrence8
Lymphoma7
Lymphoma, Large B-Cell, Diffuse7
Lymphoma, Follicular6
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma, Mantle-Cell5
Burkitt Lymphoma4
Leukemia, B-Cell4

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.